ES2124675A1 - "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida". - Google Patents

"formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".

Info

Publication number
ES2124675A1
ES2124675A1 ES09701693A ES9701693A ES2124675A1 ES 2124675 A1 ES2124675 A1 ES 2124675A1 ES 09701693 A ES09701693 A ES 09701693A ES 9701693 A ES9701693 A ES 9701693A ES 2124675 A1 ES2124675 A1 ES 2124675A1
Authority
ES
Spain
Prior art keywords
treatment
soluble fraction
aids patients
water
phlebodium decumanum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09701693A
Other languages
English (en)
Other versions
ES2124675B1 (es
Inventor
Ferrer Miguel Yesares
Medina Jorge A Mendoza
Caceres Giovanna Ruiz
Garcia Antonio Alcaide
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helsint SAL
Original Assignee
Helsint SAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsint SAL filed Critical Helsint SAL
Priority to ES09701693A priority Critical patent/ES2124675B1/es
Priority to PCT/ES1998/000220 priority patent/WO1999006058A1/es
Priority to EP98935039A priority patent/EP1040834A1/en
Publication of ES2124675A1 publication Critical patent/ES2124675A1/es
Application granted granted Critical
Publication of ES2124675B1 publication Critical patent/ES2124675B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Formulaciones a base de una fracción hidrosoluble de Phlebodium decumanum, y su uso en el tratamiento del síndrome caquéctico en enfermos de SIDA. Las formulaciones comprenden EXPLY-37, una fracción hidrosoluble de frondes, purificada y estandarizado, de la variedad de Phlebodium decumanum cultivada en la plantación del Lago Yojoa (Honduras), junto con, opcionalmente, rizoma de Phlebodium decumanum triturado, extracto de rizoma de Phlebodium decumanum, y los excipientes apropiados para la presentación de estas formulaciones en forma de polvo, cápsulas o jarabes. Estas formulaciones son adecuadas para el tratamiento por vía oral del síndrome caquéctico en enfermos de SIDA.
ES09701693A 1997-07-30 1997-07-30 "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida". Expired - Fee Related ES2124675B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES09701693A ES2124675B1 (es) 1997-07-30 1997-07-30 "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".
PCT/ES1998/000220 WO1999006058A1 (es) 1997-07-30 1998-07-29 Fracciones hidrosolubles de phlebodium decumanum y su empleo como complemento nutricional en pacientes de sida y cancer
EP98935039A EP1040834A1 (en) 1997-07-30 1998-07-29 HYDROSOLUBLE FRACTIONS OF $i(PHLEBODIUM DECUMANUM) AND USE THEREOF AS NUTRITIONAL COMPLEMENTS IN AIDS AND CANCER PATIENTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09701693A ES2124675B1 (es) 1997-07-30 1997-07-30 "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".

Publications (2)

Publication Number Publication Date
ES2124675A1 true ES2124675A1 (es) 1999-02-01
ES2124675B1 ES2124675B1 (es) 1999-10-01

Family

ID=8300251

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09701693A Expired - Fee Related ES2124675B1 (es) 1997-07-30 1997-07-30 "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".

Country Status (1)

Country Link
ES (1) ES2124675B1 (es)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES471572A1 (es) * 1978-07-07 1979-01-16 Conrad Ltd Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica
ES8104315A1 (es) * 1980-04-02 1981-04-16 Conrad Ltd Un procedimiento de obtencion de un extracto de las fraccio-nes polares de los helechos de la familia polypodiaceae.
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
ES2068163B1 (es) * 1994-05-06 1995-09-01 Esp Farmaceuticas Centrum Sa Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
ES2088770A1 (es) * 1995-02-23 1996-09-01 Esp Farmaceuticas Centrum Sa Una composicion farmaceutica con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES471572A1 (es) * 1978-07-07 1979-01-16 Conrad Ltd Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica
ES8104315A1 (es) * 1980-04-02 1981-04-16 Conrad Ltd Un procedimiento de obtencion de un extracto de las fraccio-nes polares de los helechos de la familia polypodiaceae.
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
ES2068163B1 (es) * 1994-05-06 1995-09-01 Esp Farmaceuticas Centrum Sa Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
ES2088770A1 (es) * 1995-02-23 1996-09-01 Esp Farmaceuticas Centrum Sa Una composicion farmaceutica con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.

Also Published As

Publication number Publication date
ES2124675B1 (es) 1999-10-01

Similar Documents

Publication Publication Date Title
TR200002299T2 (tr) Epotilon kompozisyonları.
CY1105170T1 (el) Συνταγοποιηση απο του στοματος δοσολογιας αστραπιαιας - τηξης
AU559218B2 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
PL314731A1 (en) S(+)-ibuprofen preparations for oral administration
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
MY125978A (en) Admantane derivatives
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
EP0846466A3 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
BR0012429A (pt) Fórmulações para il-11
AU9798198A (en) Water-dilutable, microemulsion concentrate and pour-on formulations thereof
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2001265885A1 (en) Cosmetic and/or pharmaceutical preparations that contain an extract of the plant argania spinosa
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
GB8917068D0 (en) Device for extracting dental prostheses,crowns and the like
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
ES2124675A1 (es) "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".
MD970269A (en) Clavulanates
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
AU1932997A (en) Dosage forms and uses
AU2992901A (en) Method for preparing and administering medicinal plant material
AU3543797A (en) 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations
EP0385909A3 (en) A kit or composition for the prevention or treatment of HIV-1 infections
NZ329271A (en) 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990201

Kind code of ref document: A1

Effective date: 19990201

FD1A Patent lapsed

Effective date: 20070731